Mounjaro injections for the latest medical weight loss | Effects, side effects and how to lose weight the right way

  • Published:
  • Written by the Hiro Clinic Medical Weight Loss editorial team
  • 37 min read
Medically reviewed by Dr. Hiroko Oka Reviewed byDr. Hiroko OkaCertified Member, Japanese Society of Internal Medicine Editorial policy
Mounjaro injections for the latest medical weight loss | Effects, side effects and how to lose weight the right way

In recent years, Mounjaro injections have been drawing a lot of attention as a “weight-loss injection.” Developed as a diabetes medication, this drug has a very strong weight-loss effect and is increasingly being introduced in obesity treatment and medical weight loss (medical diet). However, there are also side effects and precautions behind its effects, so accurate knowledge and management by a doctor are essential.
In this article, we explain in detail, from a doctor’s perspective, how Mounjaro injections work, their effects, their side effects, and key points for using them safely.

The short answerIf you’re busy, just read this part

  • The biggest feature of Mounjaro injections is their strong weight-loss effect
  • Because Mounjaro is a potent drug, using it on your own judgment is extremely dangerous
  • To maintain the weight-loss effect, treatment needs to continue for several months or longer

[post_category_custom_html]

1. What are Mounjaro injections? How they work and their features

1-1. Basic information about Mounjaro

Mounjaro (generic name: tirzepatide) is a once-weekly self-injected diabetes medication developed by the major US pharmaceutical company Eli Lilly.
It was approved by the US FDA in 2022 as a treatment for type 2 diabetes, and interest has grown rapidly in Japan since 2023.
It has drawn attention because it showed a weight-loss effect greater than conventional GLP-1 receptor agonists (Ozempic, Saxenda, etc.).

Although it is originally a diabetes medication, its weight-loss effect in clinical trials was so marked that its potential as an obesity medication and a medical weight-loss drug is now being researched and applied around the world.

1-2. GLP-1 and GIP: how it acts on two hormones

Conventional GLP-1 drugs acted only on the “GLP-1 receptor,” which promotes insulin secretion.
Mounjaro, on the other hand, is a **”dual agonist” that acts on both the GLP-1 receptor and the GIP receptor**.

  • GLP-1 (glucagon-like peptide-1)
    • A hormone secreted by the small intestine
    • When blood sugar rises, it acts on the pancreas to promote insulin secretion
    • Slows stomach movement and increases fullness → directly linked to appetite suppression
  • GIP (gastric inhibitory polypeptide)
    • A hormone secreted by the small intestine when you eat
    • Helps insulin secretion
    • Acts on fat cells to improve energy metabolism → promotes fat breakdown and improves insulin resistance

By acting on these two hormones at the same time, it

  1. stabilizes blood sugar,
  2. naturally suppresses appetite,
  3. and helps change the body into one that burns fat more easily,
    supporting weight loss from these three directions.

1-3. Features of Mounjaro

Compared with conventional drugs, the features of Mounjaro can be summarized as follows:

  • Once-weekly subcutaneous injection, so it takes little effort to use
  • A weight-loss effect greater than GLP-1-only drugs (average weight loss of 15–20% confirmed in clinical trials)
  • Excellent blood sugar control → diabetes and obesity can be improved at the same time
  • Side effects are mainly digestive symptoms, and serious complications are relatively rare

In particular, many patients report “a feeling that their appetite is naturally held back,” and unlike conventional “willpower diets,” it is valued for causing relatively little stress.

[post_category_custom_html]

1-4. Global reception and future outlook

In clinical trials (the SURMOUNT series), some groups showed weight loss of up to more than 20%, an effect comparable to bariatric (weight-loss) surgery.
For this reason, it has been called a “game changer in obesity treatment” overseas, and it has been suggested that it could become one of the first-choice options for obesity treatment, not just a diabetes drug.

In Japan, its use as a diabetes medication is also expanding, and formal approval in the fields of medical weight loss and obesity treatment is anticipated.

2. Effects of Mounjaro injections

2-1. Weight-loss effect

The biggest feature of Mounjaro injections is their strong weight-loss effect.
In clinical trials (such as SURMOUNT-1), giving Mounjaro to adults with obesity or overweight produced the following results.

  • Low dose (5 mg/week): average weight loss of about 15%
  • Medium dose (10 mg/week): average weight loss of about 19%
  • High dose (15 mg/week): average weight loss of about 21%

This greatly exceeds the 10–15% of conventional GLP-1 drugs (such as semaglutide) and is approaching the level of bariatric surgery.

Even more notable is the tendency that the more severe the obesity, the greater the effect. Because of this, it is also expected to be effective for patients with severe obesity who did not get sufficient results from lifestyle changes alone.

Diet

2-2. Appetite suppression and changes in eating behavior

Mounjaro is not simply a “drug that takes weight off”; it also has an effect that changes eating behavior itself.

  • Appetite naturally decreases
  • You feel full with smaller amounts
  • Cravings for high-calorie foods (fried foods, sweets) decrease
  • Satisfaction after meals lasts longer

Through these changes, instead of a “diet based on forcing yourself to hold back,” a lifestyle in which you naturally avoid overeating becomes possible.

[post_category_custom_html]

Diet guide while on Mounjaro: foods that help and foods to avoid, explained by a doctor

While taking Mounjaro, focusing on the “quality” of your meals ra...

2-3. Blood sugar control

Because Mounjaro was developed as a diabetes medication, its blood sugar–improving effect is very strong.

  • Lowers HbA1c (hemoglobin A1c) by about 1.5–2.5%
  • Suppresses high blood sugar after meals
  • Improves insulin sensitivity

As a result, a major benefit for people who also have diabetes is that blood sugar management and weight loss can be achieved at the same time.

2-4. Reducing cardiovascular risk

Obesity is a risk factor for high blood pressure, dyslipidemia and arteriosclerosis, and Mounjaro has been suggested to have effects in the following areas as well.

  • Lower blood pressure (reported average decrease of 5–7 mmHg)
  • Lower LDL cholesterol (“bad” cholesterol)
  • Improved HDL cholesterol (“good” cholesterol)
  • Lower triglycerides

These changes may contribute to preventing serious diseases such as heart attack and stroke, giving it medical significance beyond purely cosmetic purposes.

2-5. Reducing visceral fat and improving metabolism

When losing weight, attention tends to focus on the numbers, but what actually has a big impact on health is “which fat is lost.” Particularly important is the reduction of visceral fat. Visceral fat is fat that builds up around organs such as the liver and pancreas, and excessive accumulation raises the risk of lifestyle-related diseases.

With Mounjaro, it has been confirmed that visceral fat, which carries a higher metabolic risk than subcutaneous fat, is reduced preferentially. This is not just a change in appearance; it leads to improving the metabolic environment from inside the body.

The improvements that may be expected from reducing visceral fat are as follows.

Improvement of fatty liver: prevents fat from building up in the liver and protects liver function.

Reduced sleep apnea: fewer factors obstruct breathing, improving sleep quality.

Reduced joint pain (knees, lower back, etc.): less pressure from body weight and fat lightens the load on the joints.

Improvement of irregular periods and PCOS (polycystic ovary syndrome): hormonal balance is more easily restored, which also has a positive effect on reproductive function.

In this way, reducing visceral fat goes beyond changing body shape and plays a major role in raising whole-body metabolism and quality of life.

2-6. Psychological and everyday-life effects

Another major appeal is that visible changes from weight loss can improve self-esteem and quality of life (QOL).

  • Better sleep quality
  • More activity (it becomes easier to move)
  • Greater satisfaction with your appearance as your clothing size changes
  • Renewed confidence in social life

These are effects that cannot be gained from “weight loss as a number” alone, and they also help patients stay motivated.

[post_category_custom_html]

3. Side effects and precautions

3-1. Main side effects

Side effects of Mounjaro injections include the following:

  • Digestive symptoms: nausea, diarrhea, constipation, abdominal pain
  • Hypoglycemia: may occur when used together with diabetes medications
  • Risk of pancreatitis: pancreatitis has been reported in rare cases
  • Risk of gallstones: gallstones may form as weight is lost

3-2. When it cannot be used

  • People who are pregnant or breastfeeding
  • People with severe gastrointestinal disease
  • People who have had pancreatitis in the past
    Use is not recommended in these cases.

3-3. The importance of medical supervision

Because Mounjaro is a potent drug, using it on your own judgment is extremely dangerous. It must be used while receiving blood tests and health monitoring from a doctor.

[post_category_custom_html]

Not sure if it suits you? Start with a consultation.

A doctor decides whether you can use it and which dose is appropriate, based on your consultation and questionnaire.

No consultation fee (first & follow-up visits)Online consultation available

4. Comparison with other medical weight-loss options

4-1. Differences from GLP-1 drugs

Conventional GLP-1 drugs (Ozempic, Saxenda, etc.) do have a weight-loss effect, but it averages about 10–15%.
Mounjaro, on the other hand, has been reported to produce a reduction of up to nearly 20%, making it more potent.

4-2. Combining with diet and exercise

The drug alone is highly effective, but combining it with dietary restriction and exercise doubles the effect. Combining it with strength training in particular may help prevent weight regain.

4-3. Comparison with bariatric surgery

Gastric bypass and sleeve surgery can produce dramatic weight loss, but they are highly invasive and carry risks.
As a non-surgical option, Mounjaro is suited to **”people who want to lose weight reliably but don’t want to go as far as surgery.”**

5. How it is actually used and approximate costs

5-1. How it is given

  • Self-injection: once-weekly subcutaneous injection
  • Dose: start at a low dose and increase gradually (to limit side effects)

5-2. Approximate cost

It is often provided as self-pay treatment, and around ¥30,000–50,000 per month is typical. Depending on the clinic, first-visit and testing fees may be charged separately.

5-3. The importance of continuing

To maintain the weight-loss effect, treatment needs to continue for several months or longer. Rather than “temporary weight loss” from short-term use, a long-term approach alongside lifestyle improvements is recommended.

[post_category_custom_html]

6. What to know before starting Mounjaro injections

  • Always have a medical examination and tests by a doctor
  • Understand that results vary from person to person
  • If side effects occur, consult a doctor right away
  • It is not a “magic injection” but a treatment to be combined with lifestyle improvements

About self-pay treatment and off-label use

Self-pay treatment
Medical weight loss is self-pay treatment (paid in full by the patient) and is not covered by public health insurance.
Off-label use
Using medicines for weight management or weight loss may be off-label use, outside the indications approved in Japan.
Relief System for Adverse Drug Reactions
With off-label use, health damage such as a serious side effect may not be covered by Japan’s Relief System for Adverse Drug Reactions.
Individual differences and the doctor’s judgment
Effects and side effects vary from person to person. A doctor decides after a consultation whether you can use a medicine and which medicine and dose are appropriate. Please tell us in advance about any symptoms, chronic conditions or medicines you are taking.

FAQ

QWhat kind of drug is Mounjaro?
A

Mounjaro (generic name: tirzepatide) is a once-weekly self-injected diabetes medication developed by the major US pharmaceutical company Eli Lilly.

Although it is originally a diabetes medication, its weight-loss effect in clinical trials was so marked that its potential as an obesity medication and a medical weight-loss drug is now being researched and applied around the world.

QWhat side effects does Mounjaro have?
A

GIP/GLP-1 receptor agonists, including Mounjaro, are known to cause side effects, mainly digestive symptoms.

Most are mild, but serious ones occur in rare cases.

QCan I use Mounjaro on my own judgment?
A

Because Mounjaro is a potent drug, using it on your own judgment is extremely dangerous.

It must be used while receiving blood tests and health monitoring from a doctor.

QRoughly how much do Mounjaro injections cost?
A

It is often provided as self-pay treatment, and around ¥30,000–50,000 per month is typical.

Depending on the clinic, first-visit and testing fees may be charged separately.

QHow long do I need to continue Mounjaro?
A

To maintain the weight-loss effect, treatment needs to continue for several months or longer.

Rather than “temporary weight loss” from short-term use, a long-term approach alongside lifestyle improvements is recommended.

Summary

Mounjaro injections have a very strong weight-loss effect even compared with previous medical weight-loss drugs, and hold great potential in the treatment of obesity and diabetes. However, because of their potent action, the risk of side effects cannot be ignored, and using them correctly under a doctor’s guidance is essential.

For people who think “I want to lose weight reliably” or “I want to lose weight safely while also treating my diabetes,” Mounjaro injections can be a strong option. However, you should not forget that rather than relying on the medication alone, real results come only when it is built on improvements in diet, exercise and lifestyle habits.

Who to contact if side effects occur | When to see a doctor

If any of the following symptoms occur, please contact us rather than deciding on your own to wait and see. GIP/GLP-1 receptor agonists, including Mounjaro, are known to cause side effects, mainly digestive symptoms. Most are mild, but serious ones occur in rare cases.

SymptomPossible causeWhat to do
Persistent nausea or vomitingDigestive symptoms; the most common side effectPlease contact us if you remain unable to keep fluids down
Severe abdominal pain (pain radiating to the back)Possible acute pancreatitisStop the medication immediately and see a doctor
Cold sweats, palpitations, intense hunger, or feeling confused or drowsyHypoglycemiaTake sugar right away and contact us
Skin rash, difficulty breathing, or swelling of the face or throatAllergic reactionSee a doctor immediately

Contact: 0120-241-929 (hours 9:00–18:00)
If your symptoms are severe outside our hours, please go to your nearest emergency medical facility.

Each clinic’s direct phone number is listed on the clinic information page.

References

The information about medications in this article is based on the following official sources. For details on dosage and administration and on side effects, always check the latest electronic package insert.
Pharmaceuticals and Medical Devices Agency (PMDA): “Mounjaro Subcutaneous Injection Ateos, electronic package insert”
PMDA: “Drug Guide for Patients: Mounjaro Subcutaneous Injection Ateos” (PDF)
Ministry of Health, Labour and Welfare: “Prevention of lifestyle-related diseases”

When Mounjaro is used for purposes other than obesity disease, it is self-pay treatment and is not covered by Japan’s public health insurance. Effects and side effects vary from person to person.

Reviewing doctor: Hiroko Oka
Reviewing doctor

Hiroko OkaDirector, Hiro Clinic Kawaguchi (physician)

Japanese Society of Internal Medicine Chair, Fukubikai Medical Corporation / Certified Member, Japanese Society of Internal Medicine Graduated from Toho University School of Medicine and joined the Department of Internal Medicine at Keio University School of Medicine. After training in internal medicine at university and general hospitals, she has worked in obesity treatment and weight-management guidance from an internal-medicine perspective. About our medical review and editorial policy

You may also like

Back to all articles

Last updated:

Ask our AI chat AI chat